Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
ASCO Annual Meeting 2026 · Chicago, IL
5 shown of 6,251 total abstracts
  1. Abstract 98092026-06-03 · 13:00 CT · S406
    KEYNOTE-148: Keytruda (pembrolizumab) adjuvant in metastatic melanoma
    L. Paz-Ares, E. Winer, H. Rugo, et al. · Memorial Sloan Kettering Cancer Center
    Clinical Science SymposiumMelanoma📄🖼️
  2. Abstract 99672026-06-04 · 21:45 CT · S100A
    Real-world effectiveness of Keytruda vs standard of care in metastatic melanoma
    J. Brahmer, C. Robert, F. Andre, et al. · Mayo Clinic
    Clinical Science SymposiumMelanoma📄🖼️
  3. Abstract 100142026-06-03 · 19:30 CT · Hall B1
    Quality of life outcomes with Keytruda in patients with metastatic melanoma
    J. Brahmer, F. Andre, C. Robert, et al. · University of Chicago
    Clinical Science SymposiumMelanoma📄🖼️
  4. Abstract 104872026-06-05 · 19:30 CT · S406
    Biomarker subgroup analysis of Keytruda in metastatic melanoma (the KEYNOTE-538 study)
    T. Mok, C. Saura, S. Peters · Institut Gustave Roussy
    Clinical Science SymposiumMelanoma📄🖼️
  5. Abstract 104272026-06-01 · 14:45 CT · Arie Crown Theater
    Long-term follow-up of Keytruda adjuvant for metastatic melanoma: KEYNOTE-4
    S. Modi, C. Robert · Chinese University of Hong Kong
    Clinical Science SymposiumMelanoma📄🖼️
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.